PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,065,127 | -16.4% | 1,839,424 | -3.9% | 0.35% | -23.0% |
| Q1 2023 | $4,862,637 | +38.0% | 1,914,424 | +1.6% | 0.46% | +33.3% |
| Q4 2022 | $3,523,815 | -28.4% | 1,884,393 | -1.7% | 0.34% | -32.6% |
| Q3 2022 | $4,924,000 | +45.6% | 1,916,099 | +9.3% | 0.51% | +50.6% |
| Q2 2022 | $3,382,000 | -21.4% | 1,752,470 | +21.0% | 0.34% | -3.1% |
| Q1 2022 | $4,301,000 | -26.7% | 1,448,170 | +10.8% | 0.35% | -23.7% |
| Q4 2021 | $5,868,000 | +8.5% | 1,306,919 | +17.5% | 0.46% | +0.2% |
| Q3 2021 | $5,408,000 | -23.8% | 1,112,658 | +6.9% | 0.46% | -22.9% |
| Q2 2021 | $7,101,000 | +2.0% | 1,041,197 | +5.5% | 0.60% | -8.6% |
| Q1 2021 | $6,965,000 | +11.2% | 986,595 | -1.4% | 0.65% | +5.2% |
| Q4 2020 | $6,265,000 | +15.7% | 1,000,751 | 0.0% | 0.62% | -1.0% |
| Q3 2020 | $5,414,000 | +21.2% | 1,000,751 | +16.9% | 0.62% | +10.4% |
| Q2 2020 | $4,467,000 | +76.6% | 855,713 | +6.5% | 0.57% | +65.5% |
| Q1 2020 | $2,530,000 | -2.6% | 803,184 | +24.7% | 0.34% | +43.7% |
| Q4 2019 | $2,597,000 | -19.8% | 644,323 | -14.1% | 0.24% | -25.4% |
| Q3 2019 | $3,239,000 | +72.7% | 749,660 | +59.4% | 0.32% | +79.2% |
| Q2 2019 | $1,876,000 | -24.7% | 470,185 | +1.1% | 0.18% | -27.9% |
| Q1 2019 | $2,492,000 | +4.5% | 464,985 | 0.0% | 0.25% | -1.6% |
| Q4 2018 | $2,385,000 | -43.7% | 464,985 | +6.6% | 0.25% | -31.0% |
| Q3 2018 | $4,233,000 | +7.4% | 436,364 | +12.9% | 0.36% | +1.4% |
| Q2 2018 | $3,941,000 | -1.8% | 386,364 | +25.1% | 0.36% | -5.8% |
| Q1 2018 | $4,015,000 | -27.4% | 308,864 | 0.0% | 0.38% | -29.1% |
| Q4 2017 | $5,529,000 | -36.6% | 308,864 | -11.0% | 0.54% | -35.1% |
| Q3 2017 | $8,715,000 | +17.7% | 347,213 | +13.0% | 0.83% | +10.3% |
| Q2 2017 | $7,404,000 | +25.2% | 307,213 | 0.0% | 0.75% | +29.5% |
| Q1 2017 | $5,914,000 | +45.9% | 307,213 | +16.7% | 0.58% | +41.2% |
| Q4 2016 | $4,053,000 | -42.3% | 263,176 | -51.3% | 0.41% | -42.9% |
| Q3 2016 | $7,029,000 | +5.9% | 540,252 | +13.2% | 0.72% | +3.9% |
| Q2 2016 | $6,636,000 | +57.9% | 477,076 | +72.2% | 0.69% | +59.2% |
| Q1 2016 | $4,203,000 | -20.0% | 277,076 | 0.0% | 0.43% | -10.0% |
| Q4 2015 | $5,256,000 | -0.2% | 277,076 | 0.0% | 0.48% | +1.7% |
| Q3 2015 | $5,264,000 | -26.3% | 277,076 | 0.0% | 0.47% | -19.3% |
| Q2 2015 | $7,140,000 | +242.8% | 277,076 | +315.8% | 0.59% | +243.3% |
| Q1 2015 | $2,083,000 | – | 66,635 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |